These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15134217)

  • 1. Cellular targets for anticancer strategies.
    La Porta CA
    Curr Drug Targets; 2004 May; 5(4):347-55. PubMed ID: 15134217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting apoptosis pathways in cancer therapy.
    Fulda S; Debatin KM
    Curr Cancer Drug Targets; 2004 Nov; 4(7):569-76. PubMed ID: 15578914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor of apoptosis proteins as targets for anticancer therapy.
    Fulda S
    Expert Rev Anticancer Ther; 2007 Sep; 7(9):1255-64. PubMed ID: 17892425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNIO cancer conference: targeted search for anticancer drugs.
    Fischer PM
    Expert Opin Investig Drugs; 2003 Jun; 12(6):1039-44. PubMed ID: 12783608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting IAP (inhibitor of apoptosis) proteins for therapeutic intervention in tumors.
    Vucic D
    Curr Cancer Drug Targets; 2008 Mar; 8(2):110-7. PubMed ID: 18336193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cell death in tumors by activating caspases.
    MacKenzie SH; Clark AC
    Curr Cancer Drug Targets; 2008 Mar; 8(2):98-109. PubMed ID: 18336192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducing cancer cell death by targeting transcription factors.
    Kim R; Tanabe K; Emi M; Uchida Y; Inoue H; Toge T
    Anticancer Drugs; 2003 Jan; 14(1):3-11. PubMed ID: 12544253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.
    Moretti L; Yang ES; Kim KW; Lu B
    Drug Resist Updat; 2007; 10(4-5):135-43. PubMed ID: 17627865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis and non-apoptotic deaths in cancer development and treatment response.
    de Bruin EC; Medema JP
    Cancer Treat Rev; 2008 Dec; 34(8):737-49. PubMed ID: 18722718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingolipid metabolism enzymes as targets for anticancer therapy.
    Kok JW; Sietsma H
    Curr Drug Targets; 2004 May; 5(4):375-82. PubMed ID: 15134220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic targeting of apoptotic pathways in cancer.
    Meiler J; Schuler M
    Curr Drug Targets; 2006 Oct; 7(10):1361-9. PubMed ID: 17073598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptins: selective anticancer agents.
    Rollano Peñaloza OM; Lewandowska M; Stetefeld J; Ossysek K; Madej M; Bereta J; Sobczak M; Shojaei S; Ghavami S; Łos MJ
    Trends Mol Med; 2014 Sep; 20(9):519-28. PubMed ID: 25164066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical mechanisms and methods employed in drug delivery to tumors.
    Besić E
    Acta Pharm; 2007 Sep; 57(3):249-68. PubMed ID: 17878107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducing Oncoprotein Degradation to Improve Targeted Cancer Therapy.
    Ray D; Cuneo KC; Rehemtulla A; Lawrence TS; Nyati MK
    Neoplasia; 2015 Sep; 17(9):697-703. PubMed ID: 26476077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular targeting of drug delivery systems to cancer.
    Minko T; Dharap SS; Pakunlu RI; Wang Y
    Curr Drug Targets; 2004 May; 5(4):389-406. PubMed ID: 15134222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering Nanomedicines to Overcome Multidrug Resistance in Cancer Therapy.
    Beretta GL; Cavalieri F
    Curr Med Chem; 2016; 23(1):3-22. PubMed ID: 26438248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology applied to overcome tumor drug resistance.
    Gao Z; Zhang L; Sun Y
    J Control Release; 2012 Aug; 162(1):45-55. PubMed ID: 22698943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in cancer chemotherapy oriented towards new targets.
    Novotny L; Szekeres T
    Expert Opin Ther Targets; 2005 Apr; 9(2):343-57. PubMed ID: 15934920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.